Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biotrial Rejects French Phase I Inquiry Findings, Says Action Plan Already In Place

Executive Summary

The French health ministry has given Biotrial, the CRO that ran the disastrous Phase I FAAH inhibitor study in Rennes, one month in which to draw up an action plan to ensure that the "major failings" seen in the trial "cannot happen again." If it fails to do so it may lose its authorization to conduct clinical trials.

Advertisement

Related Content

Biotrial Says Will Continue To Cooperate As French Probe Manslaughter Angle in Phase I Case

Topics

Advertisement
UsernamePublicRestriction

Register

SC065266

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel